Clinical Findings on Chromosome 1 Copy Number Variations

Abstract

Copy number variants (CNVs) are a major contribution to genome variability, and the presence of CNVs on chromosome 1 is a known cause of morbidity. The main objective of this study was to contribute to chromosome 1 disease map, through the analysis of patients with chromosome 1 CNVs.

A cross-sectional study was performed using the array comparative genomic hybridization database of the Genetic Department of the Faculty of Medicine. Patients with pathogenic (P) or likely pathogenic (LP) CNVs on chromosome 1 were selected for the study. Clinical information was collected for all patients. Databases and related literature were used for genotype–phenotype correlation.

From a total of 2,516 patients included in the database we identified 24 patients (0.95%) with P (9 patients) or LP (15 patients) CNVs on chromosome 1. These CNVs account for 6.1% (24/392 CNVs) of the total P/LP CNVs in the database. Most common CNVs found were in the 1q21.1–1q21.2 region.

This study reinforces the association between chromosome 1 CNV and neurodevelopmental disorders and craniofacial dysmorphisms. Additionally, it also strengthened the idea that CNVs interpretation is not always a linear task due to the broad spectrum of variants that can be identified between benign and clearly pathogenic CNVs.

Keywords

chromosome 1 - copy number variant - array comparative genomic hybridization - neurodevelopmental disorders - 1q21.1 syndrome

Publication History

Received: 29 March 2021

Accepted: 03 February 2022

Article published online:
14 July 2022

• References

• 1 Zarrei M, MacDonald JR, Merico D, Scherer SW. A copy number variation map of the human genome. Nat Rev Genet 2015; 16 (03) 172-183
• 2 Gregory SG, Barlow KF, McLay KE. et al. The DNA sequence and biological annotation of human chromosome 1. Nature 2006; 441 (7091): 315-321
• 3 Battaglia A, Hoyme HE, Dallapiccola B. et al. Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation. Pediatrics 2008; 121 (02) 404-410
• 4 Shapira SK, McCaskill C, Northrup H. et al. Chromosome 1p36 deletions: the clinical phenotype and molecular characterization of a common newly delineated syndrome. Am J Hum Genet 1997; 61 (03) 642-650
• 5 Brunetti-Pierri N, Berg JS, Scaglia F. et al. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet 2008; 40 (12) 1466-1471
• 6 Pang H, Yu X, Kim YM. et al. Disorders associated with diverse, recurrent deletions and duplications at 1q21.1. Front Genet 2020; 11: 577
• 7 Mefford HC, Sharp AJ, Baker C. et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med 2008; 359 (16) 1685-1699
• 8 Busè M, Cuttaia HC, Palazzo D. et al. Expanding the phenotype of reciprocal 1q21.1 deletions and duplications: a case series. Ital J Pediatr 2017; 43 (01) 61
• 9 Rosenfeld JA, Traylor RN, Schaefer GB. et al; 1q21.1 Study Group. Proximal microdeletions and microduplications of 1q21.1 contribute to variable abnormal phenotypes. Eur J Hum Genet 2012; 20 (07) 754-761
• 10 Klopocki E, Schulze H, Strauss G. et al. Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome. Am J Hum Genet 2007; 80 (02) 232-240
• 11 Toriello HV. Thrombocytopenia-absent radius syndrome. Semin Thromb Hemost 2011; 37 (06) 707-712
• 12 Hemming IA, Forrest AR, Shipman P. et al. Reinforcing the association between distal 1q CNVs and structural brain disorder: a case of a complex 1q43-q44 CNV and a review of the literature. Am J Med Genet B Neuropsychiatr Genet 2016; 171B [phone]
• 13 McGowan-Jordan J, Hastings RJ, Moore S. An International System for Human Cytogenetic Nomenclature (ISCN) 2020. Paris: Karger; 2020
• 14 Riggs ER, Andersen EF, Cherry AM. et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genetics Med 2020; 22 (02) 245-257
• 15 Nagamani SC, Erez A, Shen J. et al. Clinical spectrum associated with recurrent genomic rearrangements in chromosome 17q12. Eur J Hum Genet 2010; 18 (03) 278-284
• 16 Huang Y, Shah V, Liu T, Keshvara L. Signaling through disabled 1 requires phosphoinositide binding. Biochem Biophys Res Commun 2005; 331 (04) 1460-1468
• 17 Lee GH, D'Arcangelo G. New insights into reelin-mediated signaling pathways. Front Cell Neurosci 2016; 10: 122
• 18 Folsom TD, Fatemi SH. The involvement of Reelin in neurodevelopmental disorders. Neuropharmacology 2013; 68: 122-135
• 19 Monteiro S, Pinto J, Mira Coelho A, Leão M, Dória S. Identification of copy number variation by array-CGH in Portuguese children and adolescents diagnosed with autism spectrum disorders. Neuropediatrics 2019; 50 (06) 367-377
• 20 Firth HV, Richards SM, Bevan AP. et al. DECIPHER: database of chromosomal imbalance and phenotype in humans using Ensembl resources. Am J Hum Genet 2009; 84: 524-533
• 21 Falcone M, Yariz KO, Ross DB, Foster II J, Menendez I, Tekin M. An amino acid deletion inSZT2 in a family with non-syndromic intellectual disability. PLoS One 2013; 8 (12) e82810
• 22 Edvardson S, Baumann AM, Mühlenhoff M. et al. West syndrome caused by ST3Gal-III deficiency. Epilepsia 2013; 54 (02) e24-e27
• 23 Arndt AK, Schafer S, Drenckhahn JD. et al. Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy. Am J Hum Genet 2013; 93 (01) 67-77
• 24 Albers CA, Paul DS, Schulze H. et al. Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome. Nat Genet 2012; 44 (04) 435-439 , s1–2
• 25 Manukjan G, Bösing H, Schmugge M, Strauß G, Schulze H. Impact of genetic variants on haematopoiesis in patients with thrombocytopenia absent radii (TAR) syndrome. Br J Haematol 2017; 179 (04) 606-617
• 26 Bernier R, Steinman KJ, Reilly B. et al; Simons VIP consortium. Clinical phenotype of the recurrent 1q21.1 copy-number variant. Genet Med 2016; 18 (04) 341-349
• 27 Ahel D, Horejsí Z, Wiechens N. et al. Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science 2009; 325 (5945): 1240-1243
• 28 Hamdan FF, Myers CT, Cossette P. et al; Deciphering Developmental Disorders Study. High rate of recurrent de novo mutations in developmental and epileptic encephalopathies. Am J Hum Genet 2017; 101 (05) 664-685
• 29 Walters RG, Jacquemont S, Valsesia A. et al. A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature 2010; 463 (7281): 671-675
• 30 Fernandez BA, Roberts W, Chung B. et al. Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. J Med Genet 2010; 47 (03) 195-203
• 31 Carrel D, Du Y, Komlos D. et al. NOS1AP regulates dendrite patterning of hippocampal neurons through a carboxypeptidase E-mediated pathway. J Neurosci 2009; 29 (25) 8248-8258
• 32 Bonaglia MC, Bertuzzo S, Ciaschini AM. et al. Targeted next-generation sequencing identifies the disruption of the SHANK3 and RYR2 genes in a patient carrying a de novo t(1;22)(q43;q13.3) associated with signs of Phelan-McDermid syndrome. Mol Cytogenet 2020; 13: 22
• 33 Petersen AK, Ahmad A, Shafiq M, Brown-Kipphut B, Fong CT, Anwar Iqbal M. Deletion 1q43 encompassing only CHRM3 in a patient with autistic disorder. Eur J Med Genet 2013; 56 (02) 118-122
• 34 Nakatani K, Sakaue H, Thompson DA, Weigel RJ, Roth RA. Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site. Biochem Biophys Res Commun 1999; 257 (03) 906-910
• 35 Gai D, Haan E, Scholar M, Nicholl J, Yu S. Phenotypes of AKT3 deletion: a case report and literature review. Am J Med Genet A 2015; 167A [phone]